Bak Rasmus O, Porteus Matthew H
Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Cell Rep. 2017 Jul 18;20(3):750-756. doi: 10.1016/j.celrep.2017.06.064.
The CRISPR/Cas9 system has recently been shown to facilitate high levels of precise genome editing using adeno-associated viral (AAV) vectors to serve as donor template DNA during homologous recombination (HR). However, the maximum AAV packaging capacity of ∼4.5 kb limits the donor size. Here, we overcome this constraint by showing that two co-transduced AAV vectors can serve as donors during consecutive HR events for the integration of large transgenes. Importantly, the method involves a single-step procedure applicable to primary cells with relevance to therapeutic genome editing. We use the methodology in primary human T cells and CD34 hematopoietic stem and progenitor cells to site-specifically integrate an expression cassette that, as a single donor vector, would otherwise amount to a total of 6.5 kb. This approach now provides an efficient way to integrate large transgene cassettes into the genomes of primary human cells using HR-mediated genome editing with AAV vectors.
最近研究表明,在同源重组(HR)过程中,CRISPR/Cas9系统可利用腺相关病毒(AAV)载体作为供体模板DNA,实现高水平的精确基因组编辑。然而,AAV约4.5 kb的最大包装容量限制了供体大小。在此,我们通过证明两个共转导的AAV载体可在连续的HR事件中作为供体,用于大转基因的整合,从而克服了这一限制。重要的是,该方法涉及一个适用于与治疗性基因组编辑相关的原代细胞的单步程序。我们在原代人T细胞和CD34造血干细胞及祖细胞中使用该方法,将一个表达盒位点特异性整合,若作为单个供体载体,其总长度将达6.5 kb。这种方法现在提供了一种有效的方式,可利用AAV载体通过HR介导的基因组编辑,将大转基因盒整合到原代人细胞的基因组中。